The latest technologies in gene editing and gene therapy for treating genetic blood disorders were the focus of a dedicated session at the American Society of Hematology (ASH) 2021 meeting in Atlanta.
The presentations compared new approaches to gene editing with more established approaches in the field, according to Leah Cepko, a science advisor with Science and Medicine Group, parent company of LabPulse.com. Click on the video below to learn more.